Back to Search Start Over

Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.

Authors :
Huang Z
Wang Z
Xia H
Ge Z
Yu L
Li J
Bao H
Liang Z
Cui Y
Xu Y
Source :
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2023 Jan 15; Vol. 539, pp. 162-169. Date of Electronic Publication: 2022 Dec 15.
Publication Year :
2023

Abstract

Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. Recent studies have shown that dysregulation of lncRNAs may be involved in the malignant biological behavior of tumors. Targeted regulation of lncRNAs has become a research focus of anti-tumor treatment. LncRNAs heart and neural crest derivatives expressed 2 antisense RNA 1 (HAND2-AS1) was down-regulated in various tumors and can be used as a critical tumor regulator to modulate tumor cells proliferation, apoptosis, metastasis, invasion, metabolism and drug resistance. Additionally, aberrantly expressed HAND2-AS1 was closely related to the clinical pathological characteristics of cancer patients and serve as a promising tumor diagnostic and prognostic biomarker. This article aims to review the roles of HAND2-AS1 in tumorigenesis and development, as well as the underlying molecular mechanisms and clinical significance.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2022 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3492
Volume :
539
Database :
MEDLINE
Journal :
Clinica chimica acta; international journal of clinical chemistry
Publication Type :
Academic Journal
Accession number :
36528049
Full Text :
https://doi.org/10.1016/j.cca.2022.12.010